INGREDIENTS Acetyl-L-Carnitine (from Biosint Acetyl-L-Carnitine HCI), Magnesium silicate, microcrystalline cellulose, modified cellulose (vegetarian capsule), silicon dioxide, stearic acid
Costs and access Peptide therapy is typically not covered by insurance: PT-141 (Vyleesi) may be covered for HSDD with prior authorization Most other peptides are considered "off-label" or not FDA-approved for specific uses Compounding pharmacy costs vary widely Expect to pay out-of-pocket for most peptide therapies Monthly costs range from $100-500+ depending on the peptides used
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral Ischemia
Formulation Selection We select the right formulation with or without DAC based on your goals, lifestyle, and whether we're combining with ipamorelin
The convergence of negotiated government pricing, the BALANCE Model, generic liraglutide availability, oral GLP-1 formulations, and next-generation agents like CagriSema and retatrutide suggests that coverage will continue expanding but with stronger cost management tools